Early Results from the Phase II C10403 Trial of Combination Chemotherapy for Older Adolescents and Young Adults with Newly Diagnosed ALL


Early Results from the Phase II C10403 Trial of Combination Chemotherapy for Older Adolescents and Young Adults with Newly Diagnosed ALL
Slides from a presentation at ASH 2014 and transcribed comments from a recent interview with Mikkael A Sekeres, MD, MS (1/20/15)
Stock W et al. Favorable outcomes for older adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL): Early results of US Intergroup trial C10403. Proc ASH 2014;Abstract 796.

Dr Sekeres is Professor of Medicine and Director of the Leukemia Program at the Cleveland Clinic Taussig Cancer Institute in Cleveland, Ohio.